Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | TORL-5-700 |
| Synonyms | |
| Therapy Description |
TORL-5-700 is an antibody-drug conjugate (ADC) targeting an undisclosed tumor-associated antigen, which potentially induces tumor cell death (NCI Thesaurus). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| TORL-5-700 | TORL-5700|TORL 5-700|TORL5-700 | TORL-5-700 is an antibody-drug conjugate (ADC) targeting an undisclosed tumor-associated antigen, which potentially induces tumor cell death (NCI Thesaurus). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07439653 | Phase Ib/II | TORL-5-700 | A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma | Recruiting | USA | 0 |